loadpatents
Patent applications and USPTO patent grants for Schmidt; Stanley J..The latest application filed is for "substituted pyridines as inhibitors of dnmt1".
Patent | Date |
---|---|
Substituted pyridines as inhibitors of DNMT1 Grant 10,975,056 - Adams , et al. April 13, 2 | 2021-04-13 |
Substituted Pyridines As Inhibitors Of Dnmt1 App 20190194166 - ADAMS; Nicholas David ;   et al. | 2019-06-27 |
Quinoline Derivatives As Pi3 Kinase Inhibitors App 20140296224 - ADAMS; Nicholas D. ;   et al. | 2014-10-02 |
Quinoline derivatives as PI3 kinase inhibitors Grant 8,785,433 - Knight , et al. July 22, 2 | 2014-07-22 |
Quinoline Derivatives As Pi3 Kinase Inhibitors App 20140100234 - KNIGHT; Steven David ;   et al. | 2014-04-10 |
Quinoline derivatives as PI3 kinase inhibitors Grant 8,633,187 - Knight , et al. January 21, 2 | 2014-01-21 |
Fatty Acid Synthase Inhibitors App 20130237535 - Adams; Nicholas D. ;   et al. | 2013-09-12 |
Quinoline derivatives as P13 kinase inhibitors Grant 8,404,837 - Adams , et al. March 26, 2 | 2013-03-26 |
Quinoline Derivatives As Pi3 Kinase Inhibitors App 20120165321 - Adams; Nicholas D. ;   et al. | 2012-06-28 |
Quinoline derivatives as PI3 kinase inhibitors Grant 8,138,347 - Knight , et al. March 20, 2 | 2012-03-20 |
Quinazoline Derivatives As P13 Kinase Inhibitors App 20100179144 - Adams; Nicholas D. ;   et al. | 2010-07-15 |
Thiazolidinedione Derivatives As P13 Kinase Inhibitors App 20090306074 - Darcy; Michael Gerard ;   et al. | 2009-12-10 |
Quinazoline Derivatives As P13 Kinase Inhibitors App 20090018131 - ADAMS; Nicholas D. ;   et al. | 2009-01-15 |
Quinoline Derivatives As Pi3 Kinase Inhibitors App 20080300239 - Adams; Nicholas D. ;   et al. | 2008-12-04 |
Thiazolidinedione Derivatives As Pi3 Kinase Inhibitors App 20080255115 - Darcy; Michael Gerard ;   et al. | 2008-10-16 |
4-pyridazinecarboxamides and esters as interleukin-1.beta. converting enzyme inhibitors Grant 6,995,261 - Dolle , et al. February 7, 2 | 2006-02-07 |
Sulfonamides Grant 6,849,635 - Dhanak , et al. February 1, 2 | 2005-02-01 |
Sulfonamides App 20040152893 - Dhanak, Dashyant ;   et al. | 2004-08-05 |
Sulfonamides App 20040152895 - Dhanak, Dashyant ;   et al. | 2004-08-05 |
Pyridazines as interleukin-1beta converting enzyme inhibitors App 20040110725 - Dolle, Roland E. ;   et al. | 2004-06-10 |
Peptide analogs as irreversible interleukin-1beta protease inhibitors App 20040009923 - Dolle, Roland E. ;   et al. | 2004-01-15 |
Pyridazines as interleukin-1.beta. converting enzyme inhibitors Grant 6,624,166 - Dolle , et al. September 23, 2 | 2003-09-23 |
N-(pyrimidinyl)-aspartic acid analogs as interleukin-1beta converting enzyme inhibitors App 20010003750 - Dolle, Roland E. ;   et al. | 2001-06-14 |
N-(pyrimidinyl)-aspartic acid analogs as interleukin-1.beta. converting enzyme inhibitors Grant 6,162,800 - Dolle , et al. December 19, 2 | 2000-12-19 |
Pyridazines as interleukin-1.beta. converting enzyme inhibitors Grant 6,121,266 - Dolle , et al. September 19, 2 | 2000-09-19 |
.alpha.-heteroaryloxymethyl ketones as interleukin - 1 .beta. converting enzyme inhibitors Grant 5,677,283 - Dolle , et al. October 14, 1 | 1997-10-14 |
N-(pyrimidinyl)-aspartic acid analogs as interleukin-1.beta. converting enzyme inhibitors Grant 5,670,494 - Dolle , et al. September 23, 1 | 1997-09-23 |
Fused-bicyclic lactams as interleukin-1.beta. converting enzyme inhibitors Grant 5,639,745 - Dolle , et al. June 17, 1 | 1997-06-17 |
Heteroaryloxymethyl ketones as interleukin-1.beta.converting enzyme inhibitors Grant 5,585,357 - Dolle , et al. December 17, 1 | 1996-12-17 |
Peptidic ketones as interleukin-1.beta.-converting enzyme inhibitors Grant 5,585,486 - Dolle , et al. December 17, 1 | 1996-12-17 |
Fused-bicyclic lactams as interleukin-1.beta. converting enzyme inhibitors Grant 5,552,400 - Dolle , et al. September 3, 1 | 1996-09-03 |
Peptidic ketones as interleukin-1.beta.-converting enzyme inhibitors Grant 5,462,939 - Dolle , et al. October 31, 1 | 1995-10-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.